| Literature DB >> 30675969 |
Ryuji Kawaguchi1, Koji Matsumoto2, Shigeo Akira3, Ken Ishitani4, Kazuhiro Iwasaku5, Yutaka Ueda6, Ryugo Okagaki7, Hiroya Okano8, Toshimichi Oki9, Kaori Koga10, Michiko Kido11, Takumi Kurabayashi12, Yasushi Kuribayashi13, Yuichi Sato14, Kaori Shiina15, Yasushi Takai16, Satoshi Tanimura17, Osamu Chaki18, Masakazu Terauchi19, Yukiharu Todo20, Yasuyuki Noguchi21, Sayaka Nose-Ogura22, Tsukasa Baba23, Akira Hirasawa24, Takuma Fujii25, Tsuneo Fujii26, Tetsuo Maruyama27, Etsuko Miyagi28, Kaoru Yanagida29, Osamu Yoshino30, Mitsutoshi Iwashita31, Tsugio Maeda32, Takashi Minegishi33, Hiroshi Kobayashi1.
Abstract
Six years after the first edition of The Guideline for Gynecological Practice, which was jointly edited by The Japan Society of Obstetrics and Gynecology and The Japan Association of Obstetricians and Gynecologists, the third revised edition was published in 2017. The 2017 Guidelines includes 10 additional clinical questions (CQ), which brings the total to 95 CQ (12 on infectious disease, 28 on oncology and benign tumors, 27 on endocrinology and infertility and 28 on healthcare for women). Currently a consensus has been reached on the Guidelines and therefore the objective of this report is to present the general policies regarding diagnostic and treatment methods used in standard gynecological outpatient care that are considered appropriate. At the end of each answer, the corresponding recommendation level (A, B, C) is indicated.Entities:
Keywords: gynecologic oncology; gynecology; infections; reproductive endocrinology and infertility; urogynecology
Mesh：
Year: 2019 PMID： 30675969 DOI： 10.1111/jog.13831
Source DB: PubMed Journal: J Obstet Gynaecol Res ISSN： 1341-8076 Impact factor: 1.730